Prostate-specific antigen — Drug Target

All drugs that target Prostate-specific antigen — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Radioligand Therapeutic Agent [EPC]

Marketed (2)

• Pluvicto · Aaa Usa Novartis · Radioligand Therapeutic Agent [EPC] · Oncology
  Pluvicto works by binding to prostate-specific antigen (PSMA) on cancer cells, delivering a radioactive payload that kills the cells.
• Pluvicto · VA Office of Research and Development · Oncology